Pfizer's Lyrica falls short in two pain studies

Fri May 4, 2012 12:46pm EDT

People walk past the Pfizer World headquaters in New York, February 3, 2010. REUTERS/Brendan McDermid

People walk past the Pfizer World headquaters in New York, February 3, 2010.

Credit: Reuters/Brendan McDermid

Related Topics

(Reuters) - Pfizer Inc's big-selling Lyrica drug failed to help HIV patients and diabetics relieve forms of nerve pain, according to separate clinical trial results released by the drugmaker on Friday.

Pfizer said it stopped a late-stage study involving patients with HIV neuropathy, a form of nerve damage characterized by burning pain. An interim look at the data by independent advisers overseeing the study prompted Pfizer to halt the study.

Lyrica did no better than a placebo in relieving the pain, according to the interim analysis. No safety concerns were raised by the advisers, Pfizer said.

A second late-stage study tested Lyrica for patients with painful diabetic peripheral neuropathy, which is a form of nerve damage characterized by burning or shooting pain in hands and feet. About 20 percent of diabetics suffer pain resulting from nerve damage, Pfizer said.

Lyrica did not meet the main effectiveness goal of the second study.

The results appear to cut off new growth avenues for Lyrica, which is approved to treat other forms of pain as well as seizures suffered by epileptics. Lyrica sales rose 16 percent to $955 million in the first-quarter results reported by Pfizer earlier this week.

(Reporting By Lewis Krauskopf; Editing by Gerald E. McCormick)

FILED UNDER:
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
milesrf wrote:
You may want to investigate how good the ALA form of omega-3 polyunsaturated fats (available from walnuts and flaxseed) is for
helping diabetic neuropathy. Some of the diabetics I have met through the internet found that it helped.

May 07, 2012 3:52pm EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

Pictures